Can AI Improve Patient Centricity in Clinical Trials?

According to a recent discussion with leaders at healthcare solutions company Sharecare, artificial intelligence (AI) can improve patient involvement in clinical trials. Platforms that facilitate real world data (RWD) collection and analysis, such as Sharecare’s Smart Omix, are becoming valuable and necessary, but require careful consideration before implementation.

“[S]ites and sponsors should evaluate the interoperability of a technology. New devices and modalities ought to be integrated readily and/or easily into standard research platforms. Without ease of integration, the routine use of new technologies becomes unrealistic, consuming undue time, labor, and expense.” Read more here.

(Source: Jenni Spinner, Outsourcing-Pharma, 9/21/21)